Page 90 - 《中国药房》2023年9期
P. 90

阿片类药物致便秘与基因多态性的相关性
                                                                           Δ


          杨 静    1, 2, 3* ,张新宇 ,郑 磊 ,管玉瑶 ,常温来 ,林忠琨 ,张雅慧 ,付 正 (1.山东医学高等专科学校药学系,
                                                                             1 #
                                                                     4
                                             2
                                     2
                             3
                                                     2
                                                             2
          济南 250031;2.山东省立第三医院药学部,济南 250031;3.中国海洋大学医药学院,山东 青岛 266000;
          4.山东省立医院药学部,济南 250031)
          中图分类号  R971      文献标志码  A      文章编号  1001-0408(2023)09-1104-05
          DOI  10.6039/j.issn.1001-0408.2023.09.15
          摘   要  目的  探讨基因多态性对阿片类药物致便秘的影响。方法  首先通过检索指南、数据库及循证医学资料等筛选出与阿片
          类药物致便秘相关的目标基因,随后纳入100例接受阿片类药物进行镇痛治疗的癌痛患者,并根据用药后是否出现便秘分为试验
          组和对照组,每组各50例。利用PCR或荧光原位杂交法对目标基因进行检测;使用SNPStats程序进行Hardy-Weinberg平衡检验、
          基因多态性与阿片类药物致便秘的相关性分析,采用多因素Logistic回归分析阿片类药物致便秘发生的相关预测因素,绘制受试
          者工作特征(ROC)曲线分析各预测因素在预测阿片类药物致便秘方面的效能。结果  筛选出的目标基因有CYP2D6、CYP3A5*3、
          ABCB1、OPRM1。 基 因 型 检 测 结 果 显 示 ,CYP2D6(rs1065852、rs1135822、rs16947、rs28371725、rs28371735)、CYP3A5*3
         (058rs776746)、ABCB1(062rs1045642)、OPRM1(047rs1799971)等位基因频率分布均符合Hardy-Weinberg平衡检验。相关性分析
          结果显示,试验组患者CYP3A5*3(058rs776746,A>G)中的GG、AG型,OPRM1(047rs1799971,A>G)中的AA、AG型占比显著高
          于对照组(P<0.05)。多因素Logistic回归分析结果显示,用药时间及CYP3A5*3、OPRM1基因多态性可作为患者发生阿片类药物
          致便秘的预测因素(P<0.05)。ROC 曲线分析结果显示,用药时间及 CYP3A5*3、OPRM1 基因多态性的 ROC 曲线下面积分别为
          0.648、0.640、0.670,最佳截断值分别为 124.0、0.5、0.5。结论  CYP3A5*3(058rs776746,A>G)GG、AG 型,OPRM1(047rs1799971,
          A>G)AA、AG型与阿片类药物致便秘具有相关性,且上述基因型可能是患者使用阿片类药物致便秘的预测因素,同时还需要关
          注用药时间较长患者的便秘发生情况。
          关键词  阿片类药物;基因多态性;药物不良反应;便秘;个体化用药

          Study on the correlation between opioid-induced constipation and gene polymorphism
                                                                   2
                                       3
                                                     2
          YANG Jing  1, 2, 3 ,ZHANG Xinyu ,ZHENG Lei ,GUAN Yuyao ,CHANG Wenlai ,LIN Zhongkun ,ZHANG
                                                                                    2
                                                                                                    2
          Yahui ,FU Zheng (1.  Dept.  of  Pharmacy,  Shandong  Medical  College,  Jinan  250031,  China;2.  Dept.  of
                          1
               4
          Pharmacy, Shandong Provincial Third Hospital, Jinan 250031, China;3. School of Medical and Pharmaceutical
          Science,  Ocean  University  of  China,  Shandong  Qingdao  266000,  China;4.  Dept.  of  Pharmacy,  Shandong
          Provincial Hospital, Jinan 250031, China)
          ABSTRACT    OBJECTIVE  To  investigate  the  effect  of  gene  polymorphism  on  opioid-induced  constipation.  METHODS  The
          target  genes  related  to  opioid-induced  constipation  were  screened  out  through  searching  guidelines,  databases  and  evidence-based
          medical  data,  and  then  100  cancer  pain  patients  who  received  opioid  drugs  for  analgesia  were  included  as  the  study  subjects.
          According  to  whether  there  were  adverse  effects  of  constipation  after  medication  or  not,  they  were  divided  into  test  group  and
          control  group,  with  50  cases  in  each  group.  The  target  gene  was  detected  by  PCR  or  fluorescence  in  situ  hybridization.  The
          SNPStats  program  was  used  to  carry  out  Hardy-Weinberg  balance  test  and  correlation  analysis  between  gene  polymorphism  and
          opioid-induced  constipation.  The  multivariate  Logistic  regression  analysis  was  used  to  explore  the  relevant  predictive  factors  of
          opioid-induced  constipation,  and  receiver  operating  characteristic (ROC)  curve  of  subjects  was  drawn  to  analyze  the  effectiveness
          of  each  predictive  factor  in  predicting  opioid-induced  constipation.  RESULTS  CYP2D6,  CYP3A5*3,  ABCB1  and  OPRM1  were
                                                              selected  as  target  genes  for  detection.  The  results  of  genotype
              Δ 基金项目 山东省医药卫生科技发展计划项目(No.2017WS101);           detection  showed  that  the  frequency  distribution  of  CYP2D6
          山东省药品不良反应监测中心委托项目(No.2021sdadrky03);山东省            (rs1065852,  rs1135822,  rs16947,  rs28371725,  rs28371735),
          医学会治疗药物监测科研基金(No.YXH2020ZX047);济南市科技计
                                                              CYP3A5*3 (058rs776746), ABCB1 (062rs1045642),  OPRM1
          划(后补助)项目(No.202134016)
                                                             (047rs1799971)  alleles  were  consistent  with  Hardy-Weinberg
             *第一作者 副主任药师,副教授,博士。研究方向:临床药学。
          E-mail:15853199531@163.com                          balance  test.  The  correlation  analysis  results  showed  that  the
              # 通信作者 教授。研究方向:临床药学。E-mail:fz19820528@          proportion of genotype GG and AG in CYP3A5*3 (058rs776746,
          163.com                                             A>G)  and  genotype AA  and AG  in  OPRM1 (047rs1799971,


          · 1104 ·    China Pharmacy  2023 Vol. 34  No. 9                              中国药房  2023年第34卷第9期
   85   86   87   88   89   90   91   92   93   94   95